| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.5% | |
| Div Cover | 4.0 | |
| Op Mrgn | 23.6% | |
| ROCE | 33.1% |
| Latest | F'cast | |
|---|---|---|
| P/E | 48.1 | |
| PEG | 0.2 | |
| Pr/Revenue | 9.1 | |
| Pr/Book | 5.1 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 15.3% | |
| PBT | 163.7% | |
| EPS | 209.9% | |
| DPS | 2.2% |
| Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 5,052.00 | 880.00 | 387.00¢ | 21.8 | n/a | -8% | 127.00¢ | 1.5% |
| 31-Dec-21 | 5,777.00 | 1,226.00 | 560.00¢ | 17.9 | 0.4 | +45% | 130.00¢ | 1.3% |
| 31-Dec-22 | 5,517.00 | 511.00 | 221.00¢ | 33.3 | n/a | -60% | 133.00¢ | 1.8% |
| 31-Dec-23 | 4,867.00 | 441.00 | 181.00¢ | 43.6 | n/a | -18% | 136.00¢ | 1.7% |
| 31-Dec-24 | 5,613.00 | 1,163.00 | 561.00¢ | 34.3 | 0.2 | +210% | 139.00¢ | 0.7% |
| Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-25 | 7,490.46 | 1,752.83 | 810.33¢ | 33.3 | 0.7 | +44% | 139.69¢ | 0.0% |
| 31-Dec-26 | 8,434.93 | 2,243.57 | 1,020.75¢ | 26.4 | 1.0 | +26% | 143.86¢ | 0.0% |
| 31-Dec-27 | 9,526.24 | 2,919.51 | 1,306.67¢ | 20.6 | 0.7 | +28% | 147.81¢ | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| Belgium's UCB to buy US-based Ra Pharmaceuticals... | 10-Oct-2019 | ShareCast |
| GSK gets emerging markets boost with UCB deal | 24-Jan-2009 | Telegraph |
| UCB confident on drug go-ahead | 21-Aug-2007 | The Scotsman |
| Fellner shuffles Acambis board | 08-Mar-2007 | Telegraph |
| Currency | Euro |
| Share Price | 254.55 |
| Change Today | -15.15 |
| % Change | -5.62 % |
| 52 Week High | 285.40 |
| 52 Week Low | 129.35 |
| Volume | 109,841 |
| Shares Issued | 190.00m |
| Market Cap | 48,365m |
| Beta | 2.07 |
| Strong Buy | 6 |
| Buy | 11 |
| Neutral | 3 |
| Sell | 0 |
| Strong Sell | 1 |
| Total | 21 |

| Time | Volume / Share Price |
| 13:08 | 38 @ 254.30 |
| 13:08 | 9 @ 253.90 |
| 13:08 | 25 @ 253.90 |
| 13:08 | 2 @ 254.30 |
| 13:08 | 26 @ 253.90 |
You are here: research